Beverly Hills, CA6 Active Studies

Heart Disease Clinical Trials in Beverly Hills, CA

Find 6 actively recruiting heart disease clinical trials in Beverly Hills, CA. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
23,289
Enrolling

Recruiting Heart Disease Studies in Beverly Hills

About Heart Disease Clinical Trials in Beverly Hills

Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.

There are currently 6 heart disease clinical trials recruiting participants in Beverly Hills, CA. These studies are seeking a combined 23,289 participants. Research is being sponsored by Eli Lilly and Company, Duke University, Novartis Pharmaceuticals and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Disease Clinical Trials in Beverly Hills — FAQ

Are there heart disease clinical trials in Beverly Hills?

Yes, there are 6 heart disease clinical trials currently recruiting in Beverly Hills, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Beverly Hills?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Beverly Hills research site will contact you about next steps.

Are clinical trials in Beverly Hills free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Beverly Hills studies also compensate for your time and travel.

What heart disease treatments are being tested?

The 6 active trials in Beverly Hills are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.

Data updated July 18, 2026 from ClinicalTrials.gov